DBV Technologies SA

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

08 Jul 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

05 Jun 2024 15:30:00 By Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024

04 Jun 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Plan to Implement ADS Ratio Change

31 May 2024 08:51:12 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI 2024 Congress

30 May 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Plan to Implement ADS Ratio Change

17 May 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Results of its 2024 Combined General Meeting

16 May 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming Investor Conferences

09 May 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update

07 May 2024 15:30:00 By Nasdaq GlobeNewswire

Combined General Meeting of May 16, 2024

25 Apr 2024 15:30:00 By Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024

04 Apr 2024 15:43:40 By Nasdaq GlobeNewswire

DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document

08 Mar 2024 08:33:25 By Nasdaq GlobeNewswire

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

07 Mar 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024

04 Mar 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI 2024 Congress

20 Feb 2024 15:30:00 By Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

16 Jan 2024 15:30:00 By Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  

04 Dec 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

09 Nov 2023 15:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023

06 Nov 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present New Data at ACAAI 2023

02 Nov 2023 15:30:00 By Nasdaq GlobeNewswire